Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations

Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thu...

Full description

Saved in:
Bibliographic Details
Published inActa psychiatrica Scandinavica Vol. 136; no. 6; pp. 648 - 657
Main Authors Müller, F., Lenz, C., Dolder, P., Lang, U., Schmidt, A., Liechti, M., Borgwardt, S.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.12.2017
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. Method 100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI‐to‐ROI and ROI‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects. Results LSD caused significant alterations in all dimensions of the 5D‐ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects. Conclusion Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐HT2A‐receptor in altered states of consciousness.
AbstractList It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. 100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI-to-ROI and ROI-to-voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects. LSD caused significant alterations in all dimensions of the 5D-ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD-induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects. Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5-HT -receptor in altered states of consciousness.
Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. Method 100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI ‐to‐ ROI and ROI ‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects. Results LSD caused significant alterations in all dimensions of the 5D‐ ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD ‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects. Conclusion Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐ HT 2A ‐receptor in altered states of consciousness.
ObjectiveIt has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system.Method100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI‐to‐ROI and ROI‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects.ResultsLSD caused significant alterations in all dimensions of the 5D‐ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects.ConclusionHallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐HT2A‐receptor in altered states of consciousness.
Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. Method 100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI‐to‐ROI and ROI‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects. Results LSD caused significant alterations in all dimensions of the 5D‐ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects. Conclusion Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐HT2A‐receptor in altered states of consciousness.
Author Müller, F.
Lang, U.
Dolder, P.
Borgwardt, S.
Schmidt, A.
Liechti, M.
Lenz, C.
AuthorAffiliation 1 Department of Psychiatry (UPK) University of Basel Basel Switzerland
2 Division of Clinical Pharmacology and Toxicology Department of Biomedicine and Department of Clinical Research University Hospital Basel University of Basel Basel Switzerland
AuthorAffiliation_xml – name: 2 Division of Clinical Pharmacology and Toxicology Department of Biomedicine and Department of Clinical Research University Hospital Basel University of Basel Basel Switzerland
– name: 1 Department of Psychiatry (UPK) University of Basel Basel Switzerland
Author_xml – sequence: 1
  givenname: F.
  surname: Müller
  fullname: Müller, F.
  organization: University of Basel
– sequence: 2
  givenname: C.
  surname: Lenz
  fullname: Lenz, C.
  organization: University of Basel
– sequence: 3
  givenname: P.
  surname: Dolder
  fullname: Dolder, P.
  organization: University of Basel
– sequence: 4
  givenname: U.
  surname: Lang
  fullname: Lang, U.
  organization: University of Basel
– sequence: 5
  givenname: A.
  surname: Schmidt
  fullname: Schmidt, A.
  organization: University of Basel
– sequence: 6
  givenname: M.
  surname: Liechti
  fullname: Liechti, M.
  organization: University of Basel
– sequence: 7
  givenname: S.
  orcidid: 0000-0002-5792-3987
  surname: Borgwardt
  fullname: Borgwardt, S.
  email: stefan.borgwardt@upkbs.ch
  organization: University of Basel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28940312$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFO3DAQhi0EYpctFx6gitQbUmCcxIl9qYQWWpBWohKt1JvrOJNdr7L21k4W7Y1H6DP2STAsIHqpL5bHn74ZzX9E9q2zSMgJhTMaz7nS63BGM075HhnTEiCFoqj2yRgAaFoK-DkiRyEs45NR4IdklHFRQE6zMfl1Y7VHFbBJ-oXq1MroxGPojZ3_ffgTetVjop21qHuzMf02USFRseIxabzZoE9cm8zuLiNsbDPo6ImabtDGqt44Gz6Qg1Z1AY9f7gn58eXq-_Q6nd1-vZlezFJdFJynbdbmudK05hqh4ioreZ6XDKBoWFuwvK5pBQiigVYwAZmqkGW0FlCCqivM8gn5vPOuh3qFjUbbe9XJtTcr5bfSKSP__bFmIeduI1kpeBU7TMinF4F3v4e4Arl0g7dxZklFCQxyYCJSpztKexeCx_atAwX5lIZ8SkM-pxHhj-9nekNf1x8BugPuTYfb_6jkxfTb3U76COYqmfc
CitedBy_id crossref_primary_10_1038_s41386_020_00906_2
crossref_primary_10_1016_j_bpsc_2022_04_003
crossref_primary_10_3389_fphar_2021_749068
crossref_primary_10_1016_j_pnpbp_2024_110951
crossref_primary_10_1016_j_neuropharm_2018_03_010
crossref_primary_10_1016_j_concog_2023_103536
crossref_primary_10_1016_j_nicl_2018_03_005
crossref_primary_10_1038_s41380_022_01721_5
crossref_primary_10_1038_s41398_023_02691_0
crossref_primary_10_1007_s40263_023_01008_5
crossref_primary_10_1007_s00702_024_02757_3
crossref_primary_10_1016_j_bpsc_2023_07_010
crossref_primary_10_1038_s41386_023_01574_8
crossref_primary_10_1093_braincomms_fcac329
crossref_primary_10_1016_j_encep_2024_02_007
crossref_primary_10_1016_j_neubiorev_2022_104689
crossref_primary_10_1016_j_neurot_2024_e00322
crossref_primary_10_1080_17512433_2018_1511424
crossref_primary_10_1021_acschemneuro_8b00043
crossref_primary_10_1124_pharmrev_120_000056
crossref_primary_10_1124_pr_118_017160
crossref_primary_10_1371_journal_pcbi_1010811
crossref_primary_10_1093_braincomms_fcae194
crossref_primary_10_1055_a_1721_2914
crossref_primary_10_3389_fphar_2018_00089
crossref_primary_10_3389_fpsyg_2022_1051478
crossref_primary_10_1016_j_neuroimage_2022_119434
crossref_primary_10_1038_s41598_023_44153_z
crossref_primary_10_3390_biology12111380
crossref_primary_10_3389_fnins_2018_00007
crossref_primary_10_3389_fpsyt_2021_706017
crossref_primary_10_3389_fpsyt_2024_1386321
crossref_primary_10_1038_npp_2017_86
crossref_primary_10_1111_bcp_13918
crossref_primary_10_1016_j_euroneuro_2024_04_011
crossref_primary_10_1007_s00213_018_5055_9
crossref_primary_10_1523_JNEUROSCI_1659_20_2020
crossref_primary_10_1038_s41593_022_01177_4
crossref_primary_10_3389_fphar_2018_00208
crossref_primary_10_1016_j_drudis_2023_103804
crossref_primary_10_1038_s41583_020_0367_2
crossref_primary_10_1176_appi_ajp_2019_19010035
crossref_primary_10_1126_sciadv_abl6989
crossref_primary_10_1016_j_bpsc_2019_12_007
crossref_primary_10_1038_s41386_022_01479_y
crossref_primary_10_1038_s44220_023_00133_w
crossref_primary_10_1124_pharmrev_121_000514
crossref_primary_10_1038_s41597_022_01822_4
crossref_primary_10_1038_s41386_023_01588_2
crossref_primary_10_1080_02791072_2022_2125467
crossref_primary_10_1038_s41598_020_75019_3
crossref_primary_10_1176_appi_focus_19104
crossref_primary_10_1016_j_neubiorev_2022_104906
crossref_primary_10_1093_ijnp_pyab026
crossref_primary_10_1055_a_2261_0745
crossref_primary_10_1055_a_1981_3152
crossref_primary_10_1093_brain_awab406
crossref_primary_10_1521_pdps_2023_51_3_270
crossref_primary_10_1038_s41398_022_01846_9
crossref_primary_10_1016_j_biopsych_2019_05_019
crossref_primary_10_1016_j_nsa_2023_103929
crossref_primary_10_3389_fpsyg_2023_1100058
crossref_primary_10_3389_fnins_2023_1163600
crossref_primary_10_1124_pharmrev_121_000508
crossref_primary_10_1093_schbul_sbaa117
crossref_primary_10_1021_acschemneuro_8b00215
crossref_primary_10_1016_j_ejtd_2024_100431
crossref_primary_10_1016_j_euroneuro_2021_06_001
crossref_primary_10_1177_0269881121991569
crossref_primary_10_1016_j_neuroimage_2021_117809
crossref_primary_10_1016_j_nlm_2021_107467
crossref_primary_10_1016_j_tics_2023_01_003
crossref_primary_10_1073_pnas_1815129116
crossref_primary_10_1016_j_jcbs_2019_11_005
crossref_primary_10_3390_brainsci11111528
crossref_primary_10_1089_brain_2018_0633
crossref_primary_10_1371_journal_pone_0284271
crossref_primary_10_1097_ICU_0000000000000701
crossref_primary_10_3389_fphar_2021_711255
crossref_primary_10_1038_s41380_023_02360_0
crossref_primary_10_3174_ajnr_A8118
crossref_primary_10_1007_s00429_020_02143_1
crossref_primary_10_1016_j_neuroimage_2023_120414
crossref_primary_10_1016_j_biopsych_2022_10_021
crossref_primary_10_1177_13634615221119388
crossref_primary_10_7554_eLife_69320
crossref_primary_10_3389_fpsyg_2018_01475
crossref_primary_10_1007_s00213_022_06117_5
crossref_primary_10_1162_imag_a_00033
crossref_primary_10_1016_j_neuroimage_2019_116462
Cites_doi 10.1016/S0893-133X(98)00089-X
10.1523/JNEUROSCI.20-23-08846.2000
10.1093/schbul/sbs117
10.1007/s00213-016-4453-0
10.1073/pnas.1518377113
10.1016/S0893-133X(96)00246-1
10.1111/jnc.13398
10.1212/WNL.0b013e31829d86cc
10.1016/j.neubiorev.2016.05.037
10.1126/science.282.5395.1846
10.1017/S0033291715002901
10.1016/S1053-8119(03)00103-4
10.1001/archgenpsychiatry.2010.116
10.1038/nrn3137
10.1016/j.neuropsychologia.2012.08.023
10.1016/j.cub.2016.12.030
10.1016/S0306-4522(01)00199-3
10.1523/JNEUROSCI.5778-12.2013
10.1124/pr.115.011478
10.1523/JNEUROSCI.2015-10.2010
10.1016/0306-4522(91)90075-Y
10.1016/j.concog.2011.01.007
10.1007/s00213-006-0358-7
10.1097/ALN.0b013e318277a801
10.3389/fnsys.2014.00083
10.1016/j.neuron.2012.09.033
10.1016/j.neuroimage.2015.04.027
10.1177/0269881114555249
10.3389/fnhum.2013.00084
10.1016/j.tips.2008.06.006
10.1016/S0140-6736(00)02271-6
10.1101/cshperspect.a009621
10.1038/npp.2016.82
10.1089/brain.2012.0073
10.1016/S0304-3940(03)00547-0
10.1006/ccog.1995.1003
10.1097/00001756-199812010-00024
10.1093/cercor/bht358
10.7554/eLife.05352
10.1098/rstb.1998.0336
10.1073/pnas.1119598109
10.1016/j.tics.2010.09.001
10.1007/s00429-015-1018-7
10.1016/j.neuroimage.2013.08.048
10.1016/j.neuron.2014.03.020
10.1016/j.neuron.2016.10.024
10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P
10.1016/j.cub.2016.02.010
10.1055/s-2007-979352
10.7554/eLife.04499
10.1016/S2215-0366(16)30065-7
10.1371/journal.pone.0012412
10.1016/j.neuroimage.2012.06.036
10.1016/j.biopsych.2014.11.015
10.1016/S1053-8100(03)00017-5
ContentType Journal Article
Copyright 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd
2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd.
2017 John Wiley & Sons A/S, Published by John Wiley & Sons Ltd
Copyright_xml – notice: 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd
– notice: 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd.
– notice: 2017 John Wiley & Sons A/S, Published by John Wiley & Sons Ltd
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
K9.
5PM
DOI 10.1111/acps.12818
DatabaseName Wiley_OA刊
Wiley Unsubscribed Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
DatabaseTitleList MEDLINE
CrossRef
ProQuest Health & Medical Complete (Alumni)

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley_OA刊
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Müller et al
EISSN 1600-0447
EndPage 657
ExternalDocumentID 10_1111_acps_12818
28940312
ACPS12818
Genre article
Randomized Controlled Trial
Journal Article
GrantInformation_xml – fundername: Swiss National Science Foundation
  funderid: 320030_170249
– fundername: Swiss National Science Foundation
  grantid: 320030_170249
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACHQT
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DUUFO
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPS
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OHT
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
UPT
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YF5
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
K9.
5PM
ID FETCH-LOGICAL-c4488-f2f33ac1b8ce078a2683365004d5f453bb170e09d0f95902a7e521b9060ab7e23
IEDL.DBID 24P
ISSN 0001-690X
IngestDate Tue Sep 17 21:24:59 EDT 2024
Thu Oct 10 20:25:28 EDT 2024
Fri Aug 23 03:25:18 EDT 2024
Sat Sep 28 08:27:12 EDT 2024
Sat Aug 24 00:53:10 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords psychedelics
fMRI
hallucinogens
functional connectivity
thalamus
Language English
License Attribution-NonCommercial
2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4488-f2f33ac1b8ce078a2683365004d5f453bb170e09d0f95902a7e521b9060ab7e23
ORCID 0000-0002-5792-3987
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Facps.12818
PMID 28940312
PQID 1960503059
PQPubID 33508
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5698745
proquest_journals_1960503059
crossref_primary_10_1111_acps_12818
pubmed_primary_28940312
wiley_primary_10_1111_acps_12818_ACPS12818
PublicationCentury 2000
PublicationDate December 2017
PublicationDateYYYYMMDD 2017-12-01
PublicationDate_xml – month: 12
  year: 2017
  text: December 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Aalborg
– name: Hoboken
PublicationTitle Acta psychiatrica Scandinavica
PublicationTitleAlternate Acta Psychiatr Scand
PublicationYear 2017
Publisher Blackwell Publishing Ltd
John Wiley and Sons Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: John Wiley and Sons Inc
References 2015; 78
1999; 409
2010; 14
2016; 221
2003; 19
1998; 353
2013; 7
2012; 13
2001; 105
2003; 12
2014; 3
1991; 44
2008; 29
2013; 118
2011; 20
2016; 234
2016; 113
2016; 41
1997; 16
2011; 68
2014; 8
2010; 5
2010; 30
2016; 46
1998; 282
2012; 63
2015; 19
2000; 355
2017; 27
2000; 20
2007
1999; 20
2016; 92
2014; 84
1995; 4
2014; 82
2012; 76
2012; 109
2012; 50
2015; 25
2012; 2
2013; 39
2015; 29
2016; 3
2013; 33
2015; 114
2006; 186
2013; 81
2016; 136
2003; 346
1998; 31
2016; 26
2016; 69
2016; 68
1998; 9
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
Dolder PC (e_1_2_9_29_1) 2015; 19
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_4_1
e_1_2_9_2_1
Jones E (e_1_2_9_40_1) 2007
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_51_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_7_1
e_1_2_9_5_1
e_1_2_9_3_1
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
References_xml – volume: 12
  start-page: 413
  year: 2003
  end-page: 51
  article-title: Hallucinations: synchronisation of thalamocortical gamma oscillations underconstrained by sensory input
  publication-title: Conscious Cogn
– volume: 92
  start-page: 687
  year: 2016
  end-page: 704
  article-title: Tapping the brakes: cellular and synaptic mechanisms that regulate thalamic oscillations
  publication-title: Neuron
– volume: 25
  start-page: 1618
  year: 2015
  end-page: 28
  article-title: Human thalamus regulates cortical activity via spatially specific and structurally constrained phase‐amplitude coupling
  publication-title: Cereb Cortex
– volume: 31
  start-page: 85
  issue: Suppl 2
  year: 1998
  end-page: 91
  article-title: Blood flow and cerebral laterality in the mescaline model of psychosis
  publication-title: Pharmacopsychiatry
– volume: 355
  start-page: 1790
  year: 2000
  end-page: 1
  article-title: Restoration of thalamocortical connectivity after recovery from persistent vegetative state
  publication-title: Lancet
– volume: 3
  start-page: 619
  year: 2016
  end-page: 27
  article-title: Psilocybin with psychological support for treatment‐resistant depression: an open‐label feasibility study
  publication-title: Lancet Psychiatry
– volume: 68
  start-page: 71
  year: 2011
  end-page: 8
  article-title: Pilot study of psilocybin treatment for anxiety in patients with advanced‐stage cancer
  publication-title: Arch Gen Psychiatry
– volume: 50
  start-page: 3519
  year: 2012
  end-page: 27
  article-title: Memory signals from the thalamus: early thalamocortical phase synchronization entrains gamma oscillations during long‐term memory retrieval
  publication-title: Neuropsychologia
– volume: 8
  start-page: 83
  year: 2014
  article-title: Intralaminar and medial thalamic influence on cortical synchrony, information transmission and cognition
  publication-title: Front Syst Neurosci
– volume: 2
  start-page: 125
  year: 2012
  end-page: 41
  article-title: Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks
  publication-title: Brain Connectivity
– volume: 113
  start-page: 4853
  year: 2016
  end-page: 8
  article-title: Neural correlates of the LSD experience revealed by multimodal neuroimaging
  publication-title: Proc Natl Acad Sci USA
– volume: 7
  start-page: 84
  year: 2013
  article-title: Cross‐frequency coupling within and between the human thalamus and neocortex
  publication-title: Front Human Neurosci
– volume: 282
  start-page: 1846
  year: 1998
  end-page: 51
  article-title: Consciousness and complexity
  publication-title: Science
– volume: 19
  start-page: 402
  year: 2003
  end-page: 11
  article-title: Impaired thalamocortical connectivity in humans during general‐anesthetic‐induced unconsciousness
  publication-title: NeuroImage
– volume: 234
  start-page: 1499
  year: 2016
  end-page: 1510
  article-title: Alterations of consciousness and mystical‐type experiences after acute LSD in humans
  publication-title: Psychopharmacology
– volume: 114
  start-page: 448
  year: 2015
  end-page: 65
  article-title: Comparison of functional thalamic segmentation from seed‐based analysis and ICA
  publication-title: NeuroImage
– volume: 16
  start-page: 357
  year: 1997
  end-page: 72
  article-title: Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis
  publication-title: Neuropsychopharmacology
– volume: 29
  start-page: 445
  year: 2008
  end-page: 53
  article-title: Serotonin research: contributions to understanding psychoses
  publication-title: Trends Pharmacol Sci
– volume: 27
  start-page: 451
  year: 2017
  end-page: 7
  article-title: The fabric of meaning and subjective effects in LSD‐induced states depend on serotonin 2A receptor activation
  publication-title: Curr Biol
– volume: 105
  start-page: 379
  year: 2001
  end-page: 92
  article-title: A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex
  publication-title: Neuroscience
– volume: 221
  start-page: 1971
  year: 2016
  end-page: 84
  article-title: Functional topography of the thalamocortical system in human
  publication-title: Brain Struct Funct
– volume: 9
  start-page: 3897
  year: 1998
  end-page: 902
  article-title: Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action
  publication-title: NeuroReport
– volume: 78
  start-page: 544
  year: 2015
  end-page: 53
  article-title: Acute effects of lysergic acid diethylamide in healthy subjects
  publication-title: Biol Psychiatry
– volume: 136
  start-page: 526
  year: 2016
  end-page: 35
  article-title: Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors
  publication-title: J Neurochem
– volume: 44
  start-page: 521
  year: 1991
  end-page: 35
  article-title: Of dreaming and wakefulness
  publication-title: Neuroscience
– volume: 20
  start-page: 8846
  year: 2000
  end-page: 52
  article-title: DOI‐Induced activation of the cortex: dependence on 5‐HT2A heteroreceptors on thalamocortical glutamatergic neurons
  publication-title: J Neurosci
– volume: 186
  start-page: 93
  year: 2006
  end-page: 8
  article-title: Increased frontal and paralimbic activation following ayahuasca, the pan‐Amazonian inebriant
  publication-title: Psychopharmacology
– volume: 69
  start-page: 113
  year: 2016
  end-page: 23
  article-title: The neural mechanisms of hallucinations: A quantitative meta‐analysis of neuroimaging studies
  publication-title: Neurosci Biobehav Rev
– volume: 33
  start-page: 17827
  year: 2013
  end-page: 35
  article-title: The phase of thalamic alpha activity modulates cortical gamma‐band activity: evidence from resting‐state MEG recordings
  publication-title: J Neurosci
– volume: 26
  start-page: 1043
  year: 2016
  end-page: 50
  article-title: Increased global functional connectivity correlates with LSD‐induced ego dissolution
  publication-title: Curr Biol
– volume: 409
  start-page: 187
  year: 1999
  end-page: 209
  article-title: Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat
  publication-title: J Comp Neurol
– volume: 39
  start-page: 1343
  year: 2013
  end-page: 51
  article-title: Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis
  publication-title: Schizophr Bull
– volume: 29
  start-page: 57
  year: 2015
  end-page: 68
  article-title: LSD‐assisted psychotherapy for anxiety associated with a life‐threatening disease: a qualitative study of acute and sustained subjective effects
  publication-title: J Psychopharmacol
– volume: 19
  start-page: 1
  year: 2015
  end-page: 7
  article-title: Pharmacokinetics and concentration‐effect relationship of oral LSD in humans
  publication-title: Int J Neuropsychopharmacol
– volume: 76
  start-page: 1010
  year: 2012
  end-page: 20
  article-title: Electrophysiological low‐frequency coherence and cross‐frequency coupling contribute to BOLD connectivity
  publication-title: Neuron
– volume: 20
  start-page: 565
  year: 1999
  end-page: 81
  article-title: Neurometabolic effects of psilocybin, 3,4‐methylenedioxyethylamphetamine (MDE) and d‐methamphetamine in healthy volunteers. A double‐blind, placebo‐controlled PET study with [18F]FDG
  publication-title: Neuropsychopharmacology
– volume: 20
  start-page: 464
  year: 2011
  end-page: 86
  article-title: The thalamic dynamic core theory of conscious experience
  publication-title: Conscious Cogn
– volume: 81
  start-page: 509
  year: 2013
  end-page: 10
  article-title: From the thalamus with love: a rare window into the locus of emotional synesthesia
  publication-title: Neurology
– year: 2007
– volume: 4
  start-page: 52
  year: 1995
  end-page: 62
  article-title: On the neurophysiology of consciousness: I. An overview
  publication-title: Conscious Cogn
– volume: 118
  start-page: 59
  year: 2013
  end-page: 69
  article-title: Differential effects of deep sedation with propofol on the specific and nonspecific thalamocortical systems: a functional magnetic resonance imaging study
  publication-title: Anesthesiology
– volume: 41
  start-page: 2638
  year: 2016
  end-page: 46
  article-title: LSD acutely impairs fear recognition and enhances emotional empathy and sociality
  publication-title: Neuropsychopharmacology
– volume: 30
  start-page: 11379
  year: 2010
  end-page: 87
  article-title: Development of a large‐scale functional brain network during human non‐rapid eye movement sleep
  publication-title: J Neurosci
– volume: 3
  start-page: e05352
  year: 2014
  article-title: Corticothalamic phase synchrony and cross‐frequency coupling predict human memory formation
  publication-title: eLife
– volume: 2
  start-page: a009621
  year: 2012
  article-title: Functional neuroanatomy of the basal ganglia
  publication-title: Cold Spring Harb Perspect Med
– volume: 5
  start-page: e12412
  year: 2010
  article-title: Psychometric evaluation of the altered states of consciousness rating scale (OAV)
  publication-title: PLoS ONE
– volume: 14
  start-page: 506
  year: 2010
  end-page: 15
  article-title: The functional role of cross‐frequency coupling
  publication-title: Trends Cogn Sci
– volume: 353
  start-page: 1841
  year: 1998
  end-page: 9
  article-title: The neuronal basis for consciousness
  publication-title: Philos Trans R Soc Lond B Biol Sci
– volume: 13
  start-page: 121
  year: 2012
  end-page: 34
  article-title: Spectral fingerprints of large‐scale neuronal interactions
  publication-title: Nat Rev Neurosci
– volume: 68
  start-page: 264
  year: 2016
  end-page: 355
  article-title: Psychedelics
  publication-title: Pharmacol Rev
– volume: 3
  start-page: e04499
  year: 2014
  article-title: Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine‐induced unconsciousness
  publication-title: eLife
– volume: 346
  start-page: 137
  year: 2003
  end-page: 40
  article-title: The hallucinogen 1‐[2,5‐dimethoxy‐4‐iodophenyl]‐2‐aminopropane (DOI) increases cortical extracellular glutamate levels in rats
  publication-title: Neurosci Lett
– volume: 63
  start-page: 63
  year: 2012
  end-page: 72
  article-title: Automatic sleep staging using fMRI functional connectivity data
  publication-title: NeuroImage
– volume: 46
  start-page: 1379
  year: 2016
  end-page: 1390
  article-title: The paradoxical psychological effects of lysergic acid diethylamide (LSD)
  publication-title: Psychol Med
– volume: 84
  start-page: 320
  year: 2014
  end-page: 41
  article-title: Methods to detect, characterize, and remove motion artifact in resting state fMRI
  publication-title: NeuroImage
– volume: 109
  start-page: 2138
  year: 2012
  end-page: 43
  article-title: Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
  publication-title: Proc Natl Acad Sci USA
– volume: 82
  start-page: 695
  year: 2014
  end-page: 708
  article-title: Decoding wakefulness levels from typical fMRI resting‐state data reveals reliable drifts between wakefulness and sleep
  publication-title: Neuron
– ident: e_1_2_9_11_1
  doi: 10.1016/S0893-133X(98)00089-X
– ident: e_1_2_9_16_1
  doi: 10.1523/JNEUROSCI.20-23-08846.2000
– ident: e_1_2_9_19_1
  doi: 10.1093/schbul/sbs117
– ident: e_1_2_9_37_1
  doi: 10.1007/s00213-016-4453-0
– ident: e_1_2_9_39_1
  doi: 10.1073/pnas.1518377113
– ident: e_1_2_9_13_1
  doi: 10.1016/S0893-133X(96)00246-1
– ident: e_1_2_9_56_1
  doi: 10.1111/jnc.13398
– ident: e_1_2_9_53_1
  doi: 10.1212/WNL.0b013e31829d86cc
– ident: e_1_2_9_33_1
  doi: 10.1016/j.neubiorev.2016.05.037
– ident: e_1_2_9_28_1
  doi: 10.1126/science.282.5395.1846
– ident: e_1_2_9_3_1
  doi: 10.1017/S0033291715002901
– ident: e_1_2_9_26_1
  doi: 10.1016/S1053-8119(03)00103-4
– ident: e_1_2_9_4_1
  doi: 10.1001/archgenpsychiatry.2010.116
– ident: e_1_2_9_51_1
  doi: 10.1038/nrn3137
– ident: e_1_2_9_50_1
  doi: 10.1016/j.neuropsychologia.2012.08.023
– ident: e_1_2_9_15_1
  doi: 10.1016/j.cub.2016.12.030
– ident: e_1_2_9_18_1
  doi: 10.1016/S0306-4522(01)00199-3
– ident: e_1_2_9_47_1
  doi: 10.1523/JNEUROSCI.5778-12.2013
– ident: e_1_2_9_8_1
  doi: 10.1124/pr.115.011478
– ident: e_1_2_9_34_1
  doi: 10.1523/JNEUROSCI.2015-10.2010
– ident: e_1_2_9_54_1
  doi: 10.1016/0306-4522(91)90075-Y
– ident: e_1_2_9_23_1
  doi: 10.1016/j.concog.2011.01.007
– ident: e_1_2_9_38_1
  doi: 10.1007/s00213-006-0358-7
– ident: e_1_2_9_25_1
  doi: 10.1097/ALN.0b013e318277a801
– ident: e_1_2_9_41_1
  doi: 10.3389/fnsys.2014.00083
– ident: e_1_2_9_44_1
  doi: 10.1016/j.neuron.2012.09.033
– ident: e_1_2_9_42_1
  doi: 10.1016/j.neuroimage.2015.04.027
– ident: e_1_2_9_5_1
  doi: 10.1177/0269881114555249
– ident: e_1_2_9_46_1
  doi: 10.3389/fnhum.2013.00084
– ident: e_1_2_9_9_1
  doi: 10.1016/j.tips.2008.06.006
– ident: e_1_2_9_22_1
  doi: 10.1016/S0140-6736(00)02271-6
– volume-title: The Thalamus
  year: 2007
  ident: e_1_2_9_40_1
  contributor:
    fullname: Jones E
– volume: 19
  start-page: 1
  year: 2015
  ident: e_1_2_9_29_1
  article-title: Pharmacokinetics and concentration‐effect relationship of oral LSD in humans
  publication-title: Int J Neuropsychopharmacol
  contributor:
    fullname: Dolder PC
– ident: e_1_2_9_58_1
  doi: 10.1101/cshperspect.a009621
– ident: e_1_2_9_7_1
  doi: 10.1038/npp.2016.82
– ident: e_1_2_9_31_1
  doi: 10.1089/brain.2012.0073
– ident: e_1_2_9_17_1
  doi: 10.1016/S0304-3940(03)00547-0
– ident: e_1_2_9_21_1
  doi: 10.1006/ccog.1995.1003
– ident: e_1_2_9_14_1
  doi: 10.1097/00001756-199812010-00024
– ident: e_1_2_9_48_1
  doi: 10.1093/cercor/bht358
– ident: e_1_2_9_49_1
  doi: 10.7554/eLife.05352
– ident: e_1_2_9_27_1
  doi: 10.1098/rstb.1998.0336
– ident: e_1_2_9_12_1
  doi: 10.1073/pnas.1119598109
– ident: e_1_2_9_45_1
  doi: 10.1016/j.tics.2010.09.001
– ident: e_1_2_9_43_1
  doi: 10.1007/s00429-015-1018-7
– ident: e_1_2_9_32_1
  doi: 10.1016/j.neuroimage.2013.08.048
– ident: e_1_2_9_35_1
  doi: 10.1016/j.neuron.2014.03.020
– ident: e_1_2_9_57_1
  doi: 10.1016/j.neuron.2016.10.024
– ident: e_1_2_9_55_1
  doi: 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P
– ident: e_1_2_9_20_1
  doi: 10.1016/j.cub.2016.02.010
– ident: e_1_2_9_10_1
  doi: 10.1055/s-2007-979352
– ident: e_1_2_9_24_1
  doi: 10.7554/eLife.04499
– ident: e_1_2_9_6_1
  doi: 10.1016/S2215-0366(16)30065-7
– ident: e_1_2_9_30_1
  doi: 10.1371/journal.pone.0012412
– ident: e_1_2_9_36_1
  doi: 10.1016/j.neuroimage.2012.06.036
– ident: e_1_2_9_2_1
  doi: 10.1016/j.biopsych.2014.11.015
– ident: e_1_2_9_52_1
  doi: 10.1016/S1053-8100(03)00017-5
SSID ssj0005108
Score 2.554763
Snippet Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural...
It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates...
ObjectiveIt has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 648
SubjectTerms Brain mapping
Cerebral cortex
Consciousness
Cross-Over Studies
Double-Blind Method
Excitability
fMRI
functional connectivity
Functional magnetic resonance imaging
Hallucinations
Hallucinations - chemically induced
hallucinogens
Humans
LSD
Lysergic acid diethylamide
Lysergic Acid Diethylamide - pharmacology
Lysergide
Magnetic Resonance Imaging
Neural networks
Original
psychedelics
Rest
Sensory integration
Serotonin S2 receptors
Thalamus
Thalamus - diagnostic imaging
Thalamus - drug effects
Thalamus - physiopathology
Title Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Facps.12818
https://www.ncbi.nlm.nih.gov/pubmed/28940312
https://www.proquest.com/docview/1960503059
https://pubmed.ncbi.nlm.nih.gov/PMC5698745
Volume 136
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB48QHwRb-tFQJ-EStr0CvgiHoioLB6wbzVJE1aQKu767k_wN_pLnEm76y6C4EspNA1lpnMlX74B2JdpkqlIu1ALlYVJYfJQYiQPTVxEkZU2z_zSwPVNdvGQXHbT7hQcDc_CNPwQowU3sgzvr8nAle6PGbkyr_1D2gcqpmGWKGOIOT9OOj8Aj4g3fhgLZqwBuy05KeF4ft6dDEe_cszfUMnxFNbHoPNFWGiTR3bcaHsJpmy9DHPX7fb4CjyitRPI3FZs0FPP1GqeUe8NDE9fH5_-7BAzhGwxTc8IpvpMMSKyZNUbATTYi2NXd6c4GEt1VHrFqNfKO87eLOytwsP52f3JRdi2UAgN1l1F6GInhDKRLozFZEDFWSEEJmU8qVKXpELrKOeWy4o7SUQuKrcYz7XkGVc6t7FYg5n6pbYbwLjmyhmnhM11oqNUob1agdHdFSmvTB7A3lCS5WvDlFEOKwySd-nlHcD2UMhlay34BMuolDyPDGC9kfdoCiwIE3Q8cQD5hCZGA4gfe_JJ_dTzPNlpJonMP4ADr7M_vqo8Punc-bvN_wzegvmYorxHt2zDzODt3e5gjjLQu_5XxOvpbfwNM1Hljw
link.rule.ids 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB6VRSpcChQoaSlYoqdKWTlxnkfEQ1vYRYiHtLdgO7ZAVAHt49ITP4Hf2F_SGSe7sEVCglskO1bi8Yy_GY-_AfiRx1EiA2V9JWTiR5lO_Rx3cl-HWRCY3KSJCw30TpLOZXTUj_tNbg7dhan5IaYBN9IMZ69JwSkg_UzLpb4ftukgKJuDedR3QZUb9s-e2KNwudWGGD1mdAL7DTspJfI8vTu7H70AmS9zJZ9jWLcJHS7VlVaHjruQck9u2-ORaus__zE7vvv_luFTA0_Zbr2eVuCDqT7Dx15zAL8KV2hPKI3dlGx0LX9TMXtG1T1wA_z78OhuJzFNuTO6rkrB5JBJRlSZrBxQCgi7s6x7vo-db6oSl1XJqJrLGEevQ4drcHl4cLHX8ZsiDb5Gzy7zbWiFkDpQmTYIN2SYZEIg7ONRGdsoFkoFKTc8L7nNiSpGpgYRg8p5wqVKTSjWoVXdVWYDGFdcWm2lMKmKVBBLtAhGIH6wWcxLnXqwMxFVcV9zcRQTH4Ymq3CT5cHmRIpFo4_Ygo5aTLYt9-BLLdDpEOhyRmjaQg_SGVFPOxAD92xLdXPtmLjjJKdyAR78dJJ85auK3b3Tc_f09S2dt2Ghc9HrFt1fJ8ffYDEkTOFyaTahNRqMzXdERCO15db9PzOkCUE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB48QHwRb-sZ0CehkjbpBb6IunizoMK-1SRNWEHWRdd3f4K_0V_iTNpdXQTBt0LSUGY6x5dMvgHYKxKZqki7UAuVhjI3WVhgJA9NnEeRLWyW-q2B65v07F5edJLOBBwO78LU_BCjDTeyDO-vycD7lfth5Mr0Xw_oHCifhGmJeTgx58ey_V3gEfHaDyNgRgzYachJqY7n-93xcPQrx_xdKvkzhfUxqDUPc03yyI5qbS_AhO0twsx1czy-BA9o7VRkbis26KonajXPqPcGhqfP9w9_d4gZqmwxdc8Ipl6ZYkRkyaoXKtBgz45d3Z7gZITqqPSKUa-VN1y93thbhvvW6d3xWdi0UAgN4q48dLETQplI58ZiMqDiNBcCkzIuq8TJRGgdZdzyouKuICIXlVmM57rgKVc6s7FYganec8-uAeOaK2ecEjbTUkeJQnu1AqO7yxNemSyA3aEky37NlFEOEQbJu_TyDmBzKOSysRYcQRiVkOcpAlit5T1aAgGhRMcTB5CNaWI0gfixx0d6j13Pk52kBZH5B7DvdfbHV5VHx-1b_7T-n8k7MNM-aZVX5zeXGzAbU8D3hS6bMDV4ebNbmK4M9Lb_K78A0uDnOg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+thalamic+resting%E2%80%90state+connectivity+as+a+core+driver+of+LSD%E2%80%90induced+hallucinations&rft.jtitle=Acta+psychiatrica+Scandinavica&rft.au=M%C3%BCller%2C+F.&rft.au=Lenz%2C+C.&rft.au=Dolder%2C+P.&rft.au=Lang%2C+U.&rft.date=2017-12-01&rft.issn=0001-690X&rft.eissn=1600-0447&rft.volume=136&rft.issue=6&rft.spage=648&rft.epage=657&rft_id=info:doi/10.1111%2Facps.12818&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_acps_12818
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-690X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-690X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-690X&client=summon